Compounds > quinazolines
Page last updated: 2024-08-21

quinazolines and Allergic Cutaneous Angiitis

quinazolines has been researched along with Allergic Cutaneous Angiitis in 3 studies

Research

Studies (3)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (33.33)29.6817
2010's2 (66.67)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Biasco, G; Brandi, G; Dika, E; Maibach, H; Patrizi, A; Venturi, M1
Higashi, Y; Kanekura, T; Kawai, K; Uchimiya, H1
Boeck, S; Heinemann, V; Wollenberg, A1

Other Studies

3 other study(ies) available for quinazolines and Allergic Cutaneous Angiitis

ArticleYear
Cutaneous leukocytoclastic vasculitis due to erlotinib: just an adverse event or also a putative marker of drug efficacy?
    Cutaneous and ocular toxicology, 2013, Volume: 32, Issue:4

    Topics: Aged; Antineoplastic Agents; Carcinoma, Hepatocellular; Erlotinib Hydrochloride; Humans; Liver Neoplasms; Male; Protein Kinase Inhibitors; Quinazolines; Treatment Outcome; Vasculitis, Leukocytoclastic, Cutaneous

2013
Purpuric drug eruption with leukocytoclastic vasculitis due to gefitinib.
    The Journal of dermatology, 2010, Volume: 37, Issue:6

    Topics: Aged; Antineoplastic Agents; Female; Gefitinib; Humans; Purpura; Quinazolines; Vasculitis, Leukocytoclastic, Cutaneous

2010
Leukocytoclastic vasculitis during treatment with the oral EGFR tyrosine kinase inhibitor erlotinib.
    Annals of oncology : official journal of the European Society for Medical Oncology, 2007, Volume: 18, Issue:9

    Topics: Adenocarcinoma; Administration, Oral; Aged; Antineoplastic Agents; Carcinoma, Hepatocellular; Erlotinib Hydrochloride; Female; Humans; Leg; Liver Neoplasms; Male; Middle Aged; Pancreatic Neoplasms; Quinazolines; Vasculitis, Leukocytoclastic, Cutaneous

2007